Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
The Journal of Urology
|
March 1, 1983
Bladder mucosal grafts: experimental use as a ureteral substitute and observation of certain physical properties
R Greenberg, J W Coleman, C C Quiguyan, et al.
BMC Evolutionary Biology
|
March 21, 2012
Fellow travellers: a concordance of colonization patterns between mice and men in the North Atlantic region
E P Jones, K Skirnisson, T H McGovern, et al.
Journal of Viral Hepatitis
|
January 14, 2012
The association of HIV viral load with indirect markers of liver injury
J E Forrester, M S Rhee, B H McGovern, et al.
Clinical Pharmacokinetics
|
September 3, 2015
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy
Prajakta S Badri, Jennifer R King, Akshanth R Polepally, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 6, 2007
The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients
Barbara H McGovern, Yoav Golan, Marvin Lopez, et al.
Hepatology (Baltimore, Md.)
|
November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users
Arthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
The Journal of Urology
|
September 1, 1985
Bladder mucosal grafts: experiments with allografts in repairing bladder wall defects
J W Coleman, G Ganesan, J Amberson, et al.
Proceedings. Biological Sciences
|
September 15, 2012
The impact of past climate change on genetic variation and population connectivity in the Icelandic arctic fox
Andrew Mellows, Ross Barnett, Love Dalén, et al.
Urology
|
May 1, 1985
Experimental use of free grafts of bladder mucosa in canine bladders. Successful closure of recurrent vesicovaginal fistula utilizing bladder mucosa
J W Coleman, C Albanese, D Marion, et al.
JAMA
|
October 19, 2022
Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial
Stuart H Cohen, Thomas J Louie, Matthew Sims, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
The Journal of Urology
|
March 1, 1983
Bladder mucosal grafts: experimental use as a ureteral substitute and observation of certain physical properties
R Greenberg, J W Coleman, C C Quiguyan, et al.
BMC Evolutionary Biology
|
March 21, 2012
Fellow travellers: a concordance of colonization patterns between mice and men in the North Atlantic region
E P Jones, K Skirnisson, T H McGovern, et al.
Journal of Viral Hepatitis
|
January 14, 2012
The association of HIV viral load with indirect markers of liver injury
J E Forrester, M S Rhee, B H McGovern, et al.
Clinical Pharmacokinetics
|
September 3, 2015
Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy
Prajakta S Badri, Jennifer R King, Akshanth R Polepally, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 6, 2007
The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients
Barbara H McGovern, Yoav Golan, Marvin Lopez, et al.
Hepatology (Baltimore, Md.)
|
November 1, 2012
A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users
Arthur Y Kim, Ellen H Nagami, Christopher E Birch, et al.
The Journal of Urology
|
September 1, 1985
Bladder mucosal grafts: experiments with allografts in repairing bladder wall defects
J W Coleman, G Ganesan, J Amberson, et al.
Proceedings. Biological Sciences
|
September 15, 2012
The impact of past climate change on genetic variation and population connectivity in the Icelandic arctic fox
Andrew Mellows, Ross Barnett, Love Dalén, et al.
Urology
|
May 1, 1985
Experimental use of free grafts of bladder mucosa in canine bladders. Successful closure of recurrent vesicovaginal fistula utilizing bladder mucosa
J W Coleman, C Albanese, D Marion, et al.
JAMA
|
October 19, 2022
Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial
Stuart H Cohen, Thomas J Louie, Matthew Sims, et al.
Page
of 11